A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Doxil/Caelyx BE Study
- Status
- COMPLETED
- Phase
- PHASE1
PROFAST Intervention in Precursor Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
- Status
- RECRUITING
- Phase
- N/A
A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Alternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative Study
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
Anlotinib Hydrochloride Capsule Monotherapy and Combination Therapy Relapsed and Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
Benefits of Adapted Physical Activity for Chronic Osteoarticular Pain in Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- NA
A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Thrombosis in Patients With Multiple Myeloma in an University Medical Center
- Status
- COMPLETED
- Phase
- N/A
Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- N/A
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
- Status
- RECRUITING
- Phase
- NA
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD
- Status
- RECRUITING
- Phase
- N/A